PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 2.99% | 430.00 | 420.00 | 430.00 | 425.00 | 417.50 | 425.00 | 34,490 | 16:35:24 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -15.1 | -33.0 | - | 217 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/7/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Notice of Half-Year Report |
| 12/7/2021 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Faron to Host KOL Webinar on Clever-1 Receptor |
| 22/6/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Updated corporate presentation |
| 14/6/2021 | 11:05 | UKREG | Faron Pharmaceuticals Oy Second Price Monitoring Extn |
| 14/6/2021 | 11:00 | UKREG | Faron Pharmaceuticals Oy Price Monitoring Extension |
| 14/6/2021 | 10:33 | ALNC |  Faron Pharmaceuticals granted US patent for cancer immunotherapy drug |
| 14/6/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Bexmarilimab granted key US patent |
| 03/6/2021 | 19:20 | ALNC | BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall |
| 03/6/2021 | 07:00 | UKREG | Faron Pharmaceuticals Oy Bexmarilimab results published in CCR |
| 17/5/2021 | 17:49 | ALNC | TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |
